Clinical Trial Update: Multi-omics Merge for Ensemble Subtyping for Atherosclerotic Cardiovascular Disease

View source ↗

Summary

This clinical trial update describes a study on multi-omics ensemble subtyping for atherosclerotic cardiovascular disease, with enrollment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease

Snippet

Sponsor: Henan Province Clinical Research Center for Cardiovascular Diseases | Conditions: Atherosclerotic Cardiovascular Diseases | Status: NOT_YET_RECRUITING